Anandamide Increased Both Morphine Antinociception and Tolerance in a Rat Study

Anandamide enhanced morphine antinociception in rats but also increased the reported expression of morphine tolerance. An immediate stronger drug effect therefore did not translate into less adaptation during the experimental regimen.

The design compared activation and blockade

Male rats underwent a cumulative morphine regimen to establish tolerance. Investigators compared the endogenous cannabinoid agonist anandamide and the CB1 antagonist rimonabant using tail-flick and hot-plate tests. These thermal responses are experimental antinociception endpoints, not a complete assessment of clinical pain.

The agonist findings required both qualifiers

Anandamide combined with morphine increased antinociception, while the same research reported increased tolerance expression. Reporting only stronger analgesia would omit a central adaptation result. Injected anandamide also differs from administering THC or increasing every endocannabinoid pathway equally.

The antagonist showed a different pattern

Rimonabant attenuated morphine tolerance under the tested conditions. The comparison supports a role for cannabinoid-system manipulation but does not establish that antagonist treatment is clinically preferable or safe. The paper's conclusion is bounded by the rat protocol, doses and time points.

The study highlights a useful distinction between improving an acute response and preserving that response over repeated exposure. It does not justify selecting a cannabis product for opioid tolerance or provide a human combination regimen. The direction of an interaction can depend on which outcome is measured.

Related: interpreting cannabis tolerance claims.

Research cited

Altun A; Ozdemir E; Yildirim K; Gursoy S; Durmus N; Bagcivan I. The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats. General physiology and biophysics (2015). doi:10.4149/gpb_2015017. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Different Amygdala Findings Varied by Both Subregion and Recording Method

Apparently different cannabinoid effects within the central amygdala could not be assigned solely to anatomy when recording methods differed as well. A paper discussing its medial recordings identified this interpretive limit. The current experiment measured spontaneous transmission Varodayan and colleagues recorded spontaneous and miniature GABAergic currents from the medial subdivision…

Spread the love

Read Article: Different Amygdala Findings Varied by Both Subregion and Recording Method

CB1 and CB2 Antagonists Gave Different Answers for WIN’s Synaptic Effect

A drug capable of activating more than one cannabinoid receptor needs evidence identifying the receptor responsible for a particular effect. A rat amygdala experiment compared CB1 and CB2 antagonism rather than relying only on WIN55,212-2’s drug-class label. The agonist first reduced inhibitory-current frequency Varodayan and colleagues applied WIN to central-amygdala…

Spread the love

Read Article: CB1 and CB2 Antagonists Gave Different Answers for WIN’s Synaptic Effect

A Weaker Direct WIN Response Did Not Eliminate Its Interaction With Alcohol

After chronic alcohol exposure, an experimental cannabinoid agonist had a diminished direct effect on GABA release but still prevented an acute alcohol-related increase. Reduced sensitivity depended on which response was being examined. The direct agonist challenge was attenuated Varodayan and colleagues found that WIN55,212-2 reduced inhibitory-current frequency in alcohol-naive rat…

Spread the love

Read Article: A Weaker Direct WIN Response Did Not Eliminate Its Interaction With Alcohol

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us